Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squa...( The Study Will Compare the Results...),Health

The Study Will Compare the Results of Rosetta Genomics' microRNA-based Test, miRview(TM) Squamous, Which Differentiates Squamous From non Squamous

non Small Cell Lung Cancer, With Current Diagnostic Methods A Test Based on the miRview(TM) Technology First Approved for Clinical use Through Columbia University's High Complexity Molecular Pathology Lab

Earlier This Year Rosetta Genomics is Expecting to Launch miRview(TM) Squamous Later This

Year Through its Recently Acquired CLIA lab in Philadelphia

REHOVOT, Israel and JERSEY CITY, New Jersey, October 2 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic products, announced today the initiation of a clinical assessment study with the Johns Hopkins University School of Medicine. The study will compare Rosetta Genomics' miRview(TM) squamous, which differentiates squamous from non squamous non small cell lung cancer, with available immunohistochemistry methods.

"We are excited to be collaborating once more with the excellent scientists at Johns Hopkins University," said Dr. Dalia Cohen. "Having this microRNA-based test assessed for clinical validity by faculty at one of the country's top cancer research centers is viewed by us as a strong indication to the interest this product and our technology are generating in the oncology world."

Differentiating squamous from non squamous cell lung cancer presents a challenge to physicians, but until recently this differentiation was not particularly relevant from a therapeutic or prognostic standpoint since no drug was designed for a specific NSCLC sub-type.

A recently approved angiogenesis inhibitor for NSCLC has been shown to have severe side effects for squamous-cell lung cancer patients. Furthermore, this targeted therapy includes a black-box warning about substantially higher rates of severe or fatal hemo
'/>"/>